Ascendis Pharma A/S has grown revenue 141% a year over three years and 153% a year over five. Revenue growth, 3-year annual rate: +141% (Biotechnology median +17%). Revenue growth, 5-year rate: +153%, growth has slowed since the five-year average. Years of annual history on file: 11, FY2015 to FY2025, as filed.

ASNDAscendis Pharma A/S

Healthcare

$229.11+16% 1Y

$229.11

$189.7452 weeks$271.13

Is it growing?

Good

Growing: revenue growing +98% year on year and operating margin widening (+115.2 points).

2 good, 1 without data

Revenue trend+98% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +153% a year.

Margin direction+115.2 points operating

Trailing-twelve-month operating margin, -31.9% now against -147.1% a year earlier.

All from SEC EDGAR, as of Dec 31, 2025.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is ASND growing?

Ascendis Pharma A/S has grown revenue 141% a year over three years and 153% a year over five.

+141%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +153%
Revenue growth, 5-year rate · +141% over three · growth has slowed since the five-year average
Years of annual history on file: 11
Years of annual history on file · FY2015 to FY2025, as filed

Details›